[go: up one dir, main page]

ITMI931324A0 - Composizioni farmaceutiche contenenti sali dell'acido s(+)-2-(4-isobutilfenil) propionico con amminoacidi basici - Google Patents

Composizioni farmaceutiche contenenti sali dell'acido s(+)-2-(4-isobutilfenil) propionico con amminoacidi basici

Info

Publication number
ITMI931324A0
ITMI931324A0 IT93MI1324A ITMI931324A ITMI931324A0 IT MI931324 A0 ITMI931324 A0 IT MI931324A0 IT 93MI1324 A IT93MI1324 A IT 93MI1324A IT MI931324 A ITMI931324 A IT MI931324A IT MI931324 A0 ITMI931324 A0 IT MI931324A0
Authority
IT
Italy
Prior art keywords
isobutylphenyl
amino acids
pharmaceutical compositions
propionic acid
compositions containing
Prior art date
Application number
IT93MI1324A
Other languages
English (en)
Inventor
Federico Stroppolo
Daniele Bonadeo
Annibale Gazzaniga
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of ITMI931324A0 publication Critical patent/ITMI931324A0/it
Application filed by Zambon Spa filed Critical Zambon Spa
Priority to IT93MI001324A priority Critical patent/IT1264855B1/it
Priority to BE9400519A priority patent/BE1007193A5/fr
Priority to CH01672/94A priority patent/CH686866A5/it
Priority to GB9410987A priority patent/GB2279251A/en
Priority to FR9406817A priority patent/FR2706891B1/fr
Priority to US08/255,945 priority patent/US5510385A/en
Priority to CA002125644A priority patent/CA2125644C/en
Priority to DE4420858A priority patent/DE4420858A1/de
Priority to SE9402156A priority patent/SE9402156L/xx
Priority to ES09401336A priority patent/ES2099022B1/es
Priority to JP6136833A priority patent/JPH0710749A/ja
Priority to NL9401006A priority patent/NL9401006A/nl
Publication of ITMI931324A1 publication Critical patent/ITMI931324A1/it
Application granted granted Critical
Publication of IT1264855B1 publication Critical patent/IT1264855B1/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IT93MI001324A 1993-06-21 1993-06-21 Composizioni farmaceutiche contenenti sali dell'acido s(+)-2-(4-isobutilfenil) propionico con amminoacidi basici IT1264855B1 (it)

Priority Applications (12)

Application Number Priority Date Filing Date Title
IT93MI001324A IT1264855B1 (it) 1993-06-21 1993-06-21 Composizioni farmaceutiche contenenti sali dell'acido s(+)-2-(4-isobutilfenil) propionico con amminoacidi basici
BE9400519A BE1007193A5 (fr) 1993-06-21 1994-05-20 Compositions pharmaceutiques contenant les sels d'acide s(+)-2-(4-isobutylphenyl) propionique avec des aminoacides basiques.
CH01672/94A CH686866A5 (it) 1993-06-21 1994-05-30 Composizioni farmaceutiche contenenti sali dell'acido S(+)-2-(4-isobutilfenil)propionico con amminoacidi basici scelti tra L-arginina e L-lisina
GB9410987A GB2279251A (en) 1993-06-21 1994-05-31 High dose pharmaceutical compositions
FR9406817A FR2706891B1 (it) 1993-06-21 1994-06-03
US08/255,945 US5510385A (en) 1993-06-21 1994-06-07 Pharmaceutical compositions containing the salts of S(+)-2-(4-isobutylphenyl)propionic acid with basic aminoacids
CA002125644A CA2125644C (en) 1993-06-21 1994-06-10 Pharmaceutical compositions containing the salts of s(+)-2-(4-isobutylphenyl)propionic acid with basic aminoacids
DE4420858A DE4420858A1 (de) 1993-06-21 1994-06-15 Pharmazeutische Zusammensetzungen, die Salze von S(+)-2-(4-Isobutylphenyl)propionsäure mit basischen Aminosäuren enthalten
SE9402156A SE9402156L (sv) 1993-06-21 1994-06-20 Farmaceutiska kompositioner innehållande salterna av s(+)-2- (4-isobutylfenyl)-propionsyra med basiska aminosyror
ES09401336A ES2099022B1 (es) 1993-06-21 1994-06-20 Composiciones farmaceuticas que contienen las sales de acido s(+)-2-(4-isobutilfenil) propionico con aminoacidos basicos.
JP6136833A JPH0710749A (ja) 1993-06-21 1994-06-20 S(+)−2−(4−イソブチルフェニル)プロピオン酸と塩基性アミノ酸との塩を含有する医薬組成物
NL9401006A NL9401006A (nl) 1993-06-21 1994-06-20 Farmaceutische samenstellingen die de zouten van S(+)-2-(4-isobutylfenyl) propionzuur met basische aminozuren bevatten.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT93MI001324A IT1264855B1 (it) 1993-06-21 1993-06-21 Composizioni farmaceutiche contenenti sali dell'acido s(+)-2-(4-isobutilfenil) propionico con amminoacidi basici

Publications (3)

Publication Number Publication Date
ITMI931324A0 true ITMI931324A0 (it) 1993-06-18
ITMI931324A1 ITMI931324A1 (it) 1994-12-21
IT1264855B1 IT1264855B1 (it) 1996-10-17

Family

ID=11366435

Family Applications (1)

Application Number Title Priority Date Filing Date
IT93MI001324A IT1264855B1 (it) 1993-06-21 1993-06-21 Composizioni farmaceutiche contenenti sali dell'acido s(+)-2-(4-isobutilfenil) propionico con amminoacidi basici

Country Status (12)

Country Link
US (1) US5510385A (it)
JP (1) JPH0710749A (it)
BE (1) BE1007193A5 (it)
CA (1) CA2125644C (it)
CH (1) CH686866A5 (it)
DE (1) DE4420858A1 (it)
ES (1) ES2099022B1 (it)
FR (1) FR2706891B1 (it)
GB (1) GB2279251A (it)
IT (1) IT1264855B1 (it)
NL (1) NL9401006A (it)
SE (1) SE9402156L (it)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR970701041A (ko) * 1994-02-24 1997-03-17 히데아키 고리 진통 작용 증진 제제(analgesic activity enhancer)
NZ333474A (en) * 1998-01-02 1999-06-29 Mcneil Ppc Inc A chewable tablet containing ibuprofen, fumaric acid and a non hydrocolloid binder e.g. a wax or a fat
IT1301966B1 (it) 1998-07-30 2000-07-20 Zambon Spa Composizioni farmaceutiche ad attivita' analgesica
US6251426B1 (en) 1999-09-02 2001-06-26 Banner Pharmacaps, Inc. Ibuprofen-containing softgels
US6342530B1 (en) 2000-11-14 2002-01-29 Farmacon-Il, Llc Composition and method for parenteral administration of ibuprofen d,l- or l-lysine salt
US6344479B1 (en) 2001-03-20 2002-02-05 Farmacon-Il, Llc Method of preventing retinopathy of prematurity in a neonate
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
US20040253312A1 (en) * 2001-09-28 2004-12-16 Sowden Harry S. Immediate release dosage form comprising shell having openings therein
NZ532097A (en) * 2001-09-28 2006-02-24 Mcneil Ppc Inc Dosage forms having an inner core and outer shell
US7122143B2 (en) 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
US6727286B2 (en) 2001-11-02 2004-04-27 Cumberland Pharmaceuticals Inc. Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
EP1605929B1 (en) 2003-03-21 2014-04-23 McNeil-PPC, Inc. Non-steroidal anti-inflammatory drug dosing regimen
US20040186180A1 (en) * 2003-03-21 2004-09-23 Gelotte Cathy K. Non-steroidal anti-inflammatory drug dosing regimen
US20050095300A1 (en) * 2003-10-30 2005-05-05 Wynn David W. Controlled release analgesic suspensions
US20050095299A1 (en) * 2003-10-30 2005-05-05 Wynn David W. Controlled release analgesic suspensions
US8067029B2 (en) 2004-01-13 2011-11-29 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
US7879354B2 (en) 2004-01-13 2011-02-01 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
ZA200610513B (en) * 2004-06-07 2008-06-25 Strides Arcolab Ltd Pharmaceutical composition containing a stable and clear solution of anti-inflammatory drug in soft gelatin capsule and process for producing the same
US20050281876A1 (en) 2004-06-18 2005-12-22 Shun-Por Li Solid dosage form for acid-labile active ingredient
US8673352B2 (en) * 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
BRPI0713054A2 (pt) * 2006-06-30 2012-04-17 Mcneil Ppc Inc cápsulas sólidas enchidas com lìquido contendo ibuprofeno
EP2091515B1 (en) 2006-11-21 2014-06-04 McNeil-PPC, Inc. Modified release analgesic suspensions
US9833510B2 (en) * 2007-06-12 2017-12-05 Johnson & Johnson Consumer Inc. Modified release solid or semi-solid dosage forms
MX2010001789A (es) * 2007-08-15 2010-03-10 Mcneil Ppc Inc Regimen de dosificacion de ibuprofeno de liberacion inmediata y liberacion sostenida.
US8143314B1 (en) * 2007-09-13 2012-03-27 Robert Carl Stover Methods and formulations for treating ineffective or decreased esophageal motility
CN101390844B (zh) * 2007-09-23 2011-11-09 天津医科大学 精氨酸布洛芬片剂及其制备方法
CN101265178A (zh) * 2008-04-25 2008-09-17 北京阜康仁生物制药科技有限公司 一种右旋布洛芬的氨基酸盐及其药用组合物
KR101946297B1 (ko) * 2008-12-04 2019-02-11 충시 위 고투과력을 가진 조성물 및 이의 적용
JP5977672B2 (ja) * 2009-04-27 2016-08-24 ラボラトリオ デ アプリカシオネス ファルマコディナミカス,エセ.アー.Laboratorio De Aplicaciones Farmacodinamicas,S.A. イブプロフェンリシナートの経口投与用の懸濁液
CN101978955A (zh) * 2010-11-05 2011-02-23 航天中心医院 右旋布洛芬氨基酸盐片剂及其制备方法
EP2594266B1 (en) * 2011-11-17 2014-07-30 Zambon S.p.A. Pharmaceutical solid compositions containing ibuprofen salts
WO2013119466A1 (en) 2012-02-07 2013-08-15 Mcneil-Ppc, Inc. Rapidly disintegrating coated tablets
EP2897584A1 (en) 2012-09-18 2015-07-29 McNeil-PPC, Inc. Low melting propionic acid derivative particles for use in oral dosage forms
CN104640571A (zh) 2012-09-18 2015-05-20 麦克内尔-Ppc股份有限公司 包含低熔点丙酸衍生物颗粒的缓释口服剂型
US10583089B2 (en) 2016-07-19 2020-03-10 Johnson & Johnson Consumer Inc. Tablets having discontinuous coated regions
MA45713A (fr) 2016-07-19 2019-05-29 Johnson & Johnson Consumer Inc Comprimés ayant des régions revêtues discontinues
CA3043487A1 (en) 2016-11-21 2018-05-24 Just Biotherapeutics, Inc. Aflibercept formulations and uses thereof
EP3713591A1 (en) 2017-11-20 2020-09-30 Just-Evotec Biologics, Inc. Aflibercept formulations containing a lysine salt as tonicifying agent and uses thereof
BR112020014457A8 (pt) 2018-01-22 2022-07-26 Currahee Holding Company Inc Cápsulas perfuradas
PL3996699T3 (pl) 2019-07-09 2023-10-30 Farmalider, S.A. Kombinacja ibuprofenu i tramadolu do uśmierzania bólu
US20210378968A1 (en) 2020-05-28 2021-12-09 Johnson & Johnson Consumer Inc. Multi-cavity customizable dosage forms

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1209667B (it) * 1985-11-12 1989-08-30 Zambon Spa Composizione effeverscente adattivita' analgesica.
IT1197038B (it) * 1986-08-01 1988-11-25 Zambon Spa Composizione farmaceutica ad attivita' analgesica
US5200558A (en) * 1989-10-17 1993-04-06 Merck & Co., Inc. S(+)-ibuprofen-L-amino acid and S(+)-ibuprofen-D-amino acid as onset-hastened enhanced analgesics
ATE128452T1 (de) * 1989-10-17 1995-10-15 Merck & Co Inc S(+)-ibuprofen-l-aminosäure und s(+)-ibuprofen-d- aminosäure als analgetika mit grösserem pharmakologischem potential.
US4994604A (en) * 1990-01-10 1991-02-19 Merck & Co., Inc. Formation and resolution of ibuprofen lysinate
US5009895A (en) * 1990-02-02 1991-04-23 Merck & Co., Inc. Sustained release with high and low viscosity HPMC
HUT59656A (en) * 1990-11-15 1992-06-29 Puetter Medice Chem Pharm Process for producing s/+/-phenyl-alkanoic acids and alpha-amino-acids containing complexes and pharmaceutical compositions containing them as active components
DK0505180T3 (da) * 1991-03-22 1997-03-24 Merck & Co Inc Farmaceutisk præparat med højt indhold af ibuprofenlysinat
US5260337A (en) * 1992-07-29 1993-11-09 Merck & Co., Inc. Ibuprofen-muscle relaxant combinations

Also Published As

Publication number Publication date
ITMI931324A1 (it) 1994-12-21
GB9410987D0 (en) 1994-07-20
FR2706891B1 (it) 1995-10-20
IT1264855B1 (it) 1996-10-17
NL9401006A (nl) 1995-01-16
CA2125644A1 (en) 1994-12-22
FR2706891A1 (it) 1994-12-30
CA2125644C (en) 2007-06-05
DE4420858A1 (de) 1994-12-22
GB2279251A (en) 1995-01-04
ES2099022A1 (es) 1997-05-01
JPH0710749A (ja) 1995-01-13
US5510385A (en) 1996-04-23
CH686866A5 (it) 1996-07-31
SE9402156D0 (sv) 1994-06-20
SE9402156L (sv) 1994-12-22
ES2099022B1 (es) 1998-01-16
BE1007193A5 (fr) 1995-04-18

Similar Documents

Publication Publication Date Title
ITMI931324A0 (it) Composizioni farmaceutiche contenenti sali dell'acido s(+)-2-(4-isobutilfenil) propionico con amminoacidi basici
IT8820859A0 (it) Impiego di sali dell'acido gamma idrossi butirrico per lapreparazione di composizioni farmaceutiche adatta ad essereimpiegate nella terapia dell'alcolismo e composizioni relative.
ITBO910112A0 (it) Formulazioni farmaceutiche per uso orale gastroresistenti contenenti sali di acidi biliari
IT1277741B1 (it) Composizioni farmaceutiche parenterali contenenti sali di alchilammonio di acidi 2-arilpropionici
RU95112575A (ru) Соль арилпропионовой кислоты, способ ее получения и фармацевтическая композиция
AU5696094A (en) Hydroxyiminoalkylindole carboxylic acid derivatives used as antagonists of excitatory amino acids
ITMI932634A0 (it) Composizione farmaceutica per uso topico contenente acido (s)-2-(4- isobutilfenil) propionico
ITMI941262A0 (it) Composizione farmaceutica solida contenente acido (s)-2-(4- isobutilfenil) propionico come principio attivo
IT1266583B1 (it) Processo per la preparazione di sali dell'acido 2-(4-isobutilfenil)- propionico
ITRM930147A0 (it) Procedimento per la preparazione di sali dell'acido clavulanico. (caso 970-9808)
KR900009557A (ko) 아미노산 메틸에스테르 무기산염의 제조법
BR9407415A (pt) Composições contendo um sal de aminoácido de agente antiinflamatório não-esteróide de ácido propiônico e caféina
ITMI942316A0 (it) Sali dell'acido s(+)-2-(4-isobutilfenil)propionico con mono-, di- e trialcanolammine
IT1291919B1 (it) Sali idrosolubili dell'acido dodecandioico e composizioni farmaceutiche e nutrizionali contenenti tali sali
IT8448807A0 (it) Sale di d,l-lisina dell'acido 1-(4clorobenzoil)-5-metossi-2-metil-1hindol-3 acetico, procedimento per la sua preparazione e composizioni farmaceutiche che lo contengono
ITMI930447A0 (it) Sali dell'acido s(+) 2-(3-benzoilfenil) propionico con basi organiche chirali, composizioni farmaceutiche che li contengono e procedimento per la loro preparazione
IT1201478B (it) Composizioni farmaceutiche idrosolubili a base di sali dell'acido (-)cis-1,2-epossipropilfosfonico con amminoacidi
ITMI940348A0 (it) Sali dell'acido 2-(3-benzoilfenil)propionico con basi organiche achirali e chirali e composizioni farmaceutiche che li contengono
IT1154267B (it) Preparato antalgico antipiretico antiinfiammatorio costituito da sali dell'acido 1-metil-5-(4-metilbenzoil)-pirrolo-2-acetico con gli aminoacidi lisina e arginina
IT8548980A0 (it) Procedimento per la preparazione di sali dell'acido ialuronico
IT8520919A0 (it) Procedimento per la preparazione dell'acido 2-(4-isobutilfenil)propionico.
ITMI962407A0 (it) Sali di amminoalcoli dell'ibuprofene
IT8019353A0 (it) Sali di aminoacidi basici adattivita' terapeutica, procedimento per la preparazione e relative composizioni farmaceutiche.
IT1204301B (it) Sale dell'acido 2',4'-difluoro-4-idrossi-3-bifenilo arbossilico,sua preparazione e composizioni farmaceutiche che lo contengono
IT8147902A0 (it) Preparati farmaceutici topici contenenti sali di acidi alcan-carbossi lici nonche' nuovi sali di acidi carbossilici e procedimento per produrli

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970522